Research progresses on interventions of obesity in children and adolescents.
10.3760/cma.j.cn112150-20220608-00592
- Author:
Nai Jun WAN
1
;
Tian ZHANG
1
Author Information
1. Department of Pediatrics, Beijing Jishuitan Hospital, Beijing 100035, China.
- Publication Type:Journal Article
- MeSH:
Adolescent;
Humans;
Child;
Pediatric Obesity/prevention & control*;
Obesity, Morbid/surgery*;
Gastric Bypass/methods*;
Metformin;
Gastrectomy/methods*;
Treatment Outcome;
Retrospective Studies
- From:
Chinese Journal of Preventive Medicine
2023;57(5):760-765
- CountryChina
- Language:Chinese
-
Abstract:
Childhood and adolescent obesity has become a global epidemic. The interventions mainly include lifestyle intervention, medication treatment and bariatric surgery. Among them, lifestyle intervention, especially intensive lifestyle intervention with participation of family members, is the first-line treatment for obesity in children and adolescents. Both medication and bariatric surgery are adjuvant treatments for severely obese children and adolescents. Currently, metformin is the most widely used drug for the treatment of obesity in children and adolescents in both China and other countries; orlistat and liraglutide are also the drugs that are safe and often used in other countries; other drugs are not recommended. As a tertiary prevention and treatment strategy for obesity, bariatric surgery should be carried out on the basis of good compliance from both the children and their family members, with the cooperation of multiple disciplines. Sleeve gastrectomy (SG) and Roux-en-Y gastric bypass (RYGB) are the most common types of procedure performed. Meanwhile, as a new treatment method, intra-gastric balloon procedure needs to be paid more attention to its efficacy and safety.
